GHW International (HKG:9933)
Hong Kong · Delayed Price · Currency is HKD 1.630
0.00 (0.00%)
Apr 17, 2026, 10:45 AM HKT
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
Methylamine Industry Series | 1.31B | 1.36B | 1.06B | 1.18B | 952.17M | |||||
Methylamine Industry Series Growth | -3.85% | 28.25% | -10.22% | 23.97% | 25.64% | |||||
Iodine Derivatives and Supporting Products | 1.26B | 991.93M | 710.71M | - | - | |||||
Iodine Derivatives and Supporting Products Growth | 27.32% | 39.57% | - | - | - | |||||
Goldenhighway New Materials | 922.56M | - | - | - | - | |||||
Advanced Materials Intermediates Series | 296.75M | 1.09B | 1.10B | - | - | |||||
Advanced Materials Intermediates Series Growth | -72.87% | -0.68% | - | - | - | |||||
Green Products | 281.46M | 200.38M | 130.39M | - | - | |||||
Green Products Growth | 40.46% | 53.67% | - | - | - | |||||
Healthcare and Wellness | 20.96M | - | - | - | - | |||||
Happy Elephant Selections | 4.78M | - | - | - | - | |||||
Others | 17.04M | 15.48M | 13.43M | 13.34M | 11.42M | |||||
Others Growth | 10.11% | 15.29% | 0.64% | 16.86% | 16.72% | |||||
Applied Chemicals Series | - | 177.37M | 178.41M | - | - | |||||
Applied Chemicals Series Growth | - | -0.58% | - | - | - | |||||
Pharmaceutical Intermediates and Active Pharmaceutical Ingredients ("apis") | - | 23.80M | 23.61M | - | - | |||||
Pharmaceutical Intermediates and Active Pharmaceutical Ingredients ("apis") Growth | - | 0.80% | - | - | - | |||||
Happy Elephant Planet, Advanced Medical and Health Products | - | 1,000.00 | 34.00K | - | - | |||||
Happy Elephant Planet, Advanced Medical and Health Products Growth | - | -97.06% | - | - | - | |||||
Polyurethane Materials | - | - | - | 698.84M | 844.95M | |||||
Polyurethane Materials Growth | - | - | - | -17.29% | 20.66% | |||||
Fine Chemicals | - | - | - | 732.11M | 438.86M | |||||
Fine Chemicals Growth | - | - | - | 66.82% | 106.40% | |||||
Medicine and supplements | - | - | - | 754.05M | 585.87M | |||||
Medicine and supplements Growth | - | - | - | 28.71% | 38.40% | |||||
Total | 4.11B | 3.86B | 3.22B | 3.38B | 2.83B | |||||
Total Growth | 6.51% | 20.02% | -4.77% | 19.25% | 34.67% |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
The Mainland of China | 3.12B | 3.02B | 2.52B | 2.78B | 2.31B | |||||
The Mainland of China Growth | 3.26% | 19.75% | -9.28% | 20.57% | - | |||||
Europe | 385.75M | 349.98M | 296.22M | 283.50M | 220.66M | |||||
Europe Growth | 10.22% | 18.15% | 4.48% | 28.48% | 13.66% | |||||
Vietnam | 238.28M | 144.95M | 87.32M | 61.39M | 85.24M | |||||
Vietnam Growth | 64.39% | 66.00% | 42.24% | -27.98% | -26.00% | |||||
Other Countries in Asia (Excluding The Mainland of China and Vietnam) | 217.60M | 212.30M | 152.78M | 122.82M | 108.05M | |||||
Other Countries in Asia (Excluding The Mainland of China and Vietnam) Growth | 2.49% | 38.96% | 24.39% | 13.67% | - | |||||
Others | 149.98M | 131.62M | 156.83M | 128.26M | 111.35M | |||||
Others Growth | 13.95% | -16.08% | 22.28% | 15.18% | 32.40% | |||||
Total | 4.11B | 3.86B | 3.22B | 3.38B | 2.83B | |||||
Total Growth | 6.51% | 20.02% | -4.77% | 19.25% | 34.67% |
Source: S&P Global Market Intelligence.